nodes	percent_of_prediction	percent_of_DWPC	metapath
Imiquimod—CYP3A4—Ifosfamide—testicular cancer	0.0101	0.308	CbGbCtD
Imiquimod—CYP1A2—Etoposide—testicular cancer	0.00922	0.281	CbGbCtD
Imiquimod—CYP3A4—Vinblastine—testicular cancer	0.00536	0.163	CbGbCtD
Imiquimod—CYP3A4—Etoposide—testicular cancer	0.00483	0.147	CbGbCtD
Imiquimod—CYP3A4—Doxorubicin—testicular cancer	0.0033	0.1	CbGbCtD
Imiquimod—Decreased appetite—Etoposide—testicular cancer	0.000705	0.000728	CcSEcCtD
Imiquimod—Diarrhoea—Ifosfamide—testicular cancer	0.000702	0.000726	CcSEcCtD
Imiquimod—Pancytopenia—Doxorubicin—testicular cancer	0.000702	0.000726	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Etoposide—testicular cancer	0.0007	0.000723	CcSEcCtD
Imiquimod—Body temperature increased—Cisplatin—testicular cancer	0.000699	0.000723	CcSEcCtD
Imiquimod—Fatigue—Etoposide—testicular cancer	0.000699	0.000722	CcSEcCtD
Imiquimod—Neuropathy peripheral—Epirubicin—testicular cancer	0.000698	0.000722	CcSEcCtD
Imiquimod—Pain—Etoposide—testicular cancer	0.000693	0.000717	CcSEcCtD
Imiquimod—Conjunctivitis—Epirubicin—testicular cancer	0.000692	0.000716	CcSEcCtD
Imiquimod—Urinary tract infection—Epirubicin—testicular cancer	0.000692	0.000716	CcSEcCtD
Imiquimod—Dysuria—Doxorubicin—testicular cancer	0.000691	0.000715	CcSEcCtD
Imiquimod—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.000687	0.00071	CcSEcCtD
Imiquimod—Haemoglobin—Methotrexate—testicular cancer	0.000687	0.00071	CcSEcCtD
Imiquimod—Haemorrhage—Methotrexate—testicular cancer	0.000683	0.000707	CcSEcCtD
Imiquimod—Dizziness—Ifosfamide—testicular cancer	0.000679	0.000702	CcSEcCtD
Imiquimod—Pharyngitis—Methotrexate—testicular cancer	0.000678	0.000701	CcSEcCtD
Imiquimod—Urinary tract disorder—Methotrexate—testicular cancer	0.000675	0.000698	CcSEcCtD
Imiquimod—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000675	0.000698	CcSEcCtD
Imiquimod—Hepatobiliary disease—Epirubicin—testicular cancer	0.000674	0.000697	CcSEcCtD
Imiquimod—Urethral disorder—Methotrexate—testicular cancer	0.00067	0.000693	CcSEcCtD
Imiquimod—Sinusitis—Epirubicin—testicular cancer	0.000668	0.000691	CcSEcCtD
Imiquimod—Feeling abnormal—Etoposide—testicular cancer	0.000668	0.000691	CcSEcCtD
Imiquimod—Nausea—Dactinomycin—testicular cancer	0.000665	0.000688	CcSEcCtD
Imiquimod—Gastrointestinal pain—Etoposide—testicular cancer	0.000663	0.000685	CcSEcCtD
Imiquimod—Infestation NOS—Doxorubicin—testicular cancer	0.000659	0.000681	CcSEcCtD
Imiquimod—Infestation—Doxorubicin—testicular cancer	0.000659	0.000681	CcSEcCtD
Imiquimod—Visual impairment—Methotrexate—testicular cancer	0.000659	0.000681	CcSEcCtD
Imiquimod—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000653	0.000676	CcSEcCtD
Imiquimod—Vomiting—Ifosfamide—testicular cancer	0.000652	0.000675	CcSEcCtD
Imiquimod—Hypersensitivity—Cisplatin—testicular cancer	0.000652	0.000674	CcSEcCtD
Imiquimod—Rash—Ifosfamide—testicular cancer	0.000647	0.000669	CcSEcCtD
Imiquimod—Dermatitis—Ifosfamide—testicular cancer	0.000646	0.000668	CcSEcCtD
Imiquimod—Erythema multiforme—Methotrexate—testicular cancer	0.000646	0.000668	CcSEcCtD
Imiquimod—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000646	0.000668	CcSEcCtD
Imiquimod—Urticaria—Etoposide—testicular cancer	0.000644	0.000666	CcSEcCtD
Imiquimod—Haemoglobin—Epirubicin—testicular cancer	0.000643	0.000665	CcSEcCtD
Imiquimod—Rhinitis—Epirubicin—testicular cancer	0.000641	0.000663	CcSEcCtD
Imiquimod—Abdominal pain—Etoposide—testicular cancer	0.000641	0.000662	CcSEcCtD
Imiquimod—Body temperature increased—Etoposide—testicular cancer	0.000641	0.000662	CcSEcCtD
Imiquimod—Urinary tract infection—Doxorubicin—testicular cancer	0.000641	0.000662	CcSEcCtD
Imiquimod—Conjunctivitis—Doxorubicin—testicular cancer	0.000641	0.000662	CcSEcCtD
Imiquimod—Haemorrhage—Epirubicin—testicular cancer	0.000639	0.000661	CcSEcCtD
Imiquimod—Eye disorder—Methotrexate—testicular cancer	0.000639	0.00066	CcSEcCtD
Imiquimod—Tinnitus—Methotrexate—testicular cancer	0.000637	0.000659	CcSEcCtD
Imiquimod—Asthenia—Cisplatin—testicular cancer	0.000635	0.000656	CcSEcCtD
Imiquimod—Pharyngitis—Epirubicin—testicular cancer	0.000635	0.000656	CcSEcCtD
Imiquimod—Urinary tract disorder—Epirubicin—testicular cancer	0.000632	0.000653	CcSEcCtD
Imiquimod—Connective tissue disorder—Epirubicin—testicular cancer	0.000628	0.00065	CcSEcCtD
Imiquimod—Urethral disorder—Epirubicin—testicular cancer	0.000627	0.000648	CcSEcCtD
Imiquimod—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000623	0.000645	CcSEcCtD
Imiquimod—Angiopathy—Methotrexate—testicular cancer	0.00062	0.000641	CcSEcCtD
Imiquimod—Sinusitis—Doxorubicin—testicular cancer	0.000618	0.000639	CcSEcCtD
Imiquimod—Immune system disorder—Methotrexate—testicular cancer	0.000617	0.000638	CcSEcCtD
Imiquimod—Visual impairment—Epirubicin—testicular cancer	0.000616	0.000637	CcSEcCtD
Imiquimod—Mediastinal disorder—Methotrexate—testicular cancer	0.000616	0.000637	CcSEcCtD
Imiquimod—Chills—Methotrexate—testicular cancer	0.000613	0.000634	CcSEcCtD
Imiquimod—Nausea—Ifosfamide—testicular cancer	0.00061	0.00063	CcSEcCtD
Imiquimod—Diarrhoea—Cisplatin—testicular cancer	0.000605	0.000626	CcSEcCtD
Imiquimod—Erythema multiforme—Epirubicin—testicular cancer	0.000605	0.000625	CcSEcCtD
Imiquimod—Alopecia—Methotrexate—testicular cancer	0.000604	0.000624	CcSEcCtD
Imiquimod—Mental disorder—Methotrexate—testicular cancer	0.000599	0.000619	CcSEcCtD
Imiquimod—Eye disorder—Epirubicin—testicular cancer	0.000598	0.000618	CcSEcCtD
Imiquimod—Hypersensitivity—Etoposide—testicular cancer	0.000597	0.000617	CcSEcCtD
Imiquimod—Tinnitus—Epirubicin—testicular cancer	0.000596	0.000616	CcSEcCtD
Imiquimod—Erythema—Methotrexate—testicular cancer	0.000595	0.000615	CcSEcCtD
Imiquimod—Malnutrition—Methotrexate—testicular cancer	0.000595	0.000615	CcSEcCtD
Imiquimod—Haemoglobin—Doxorubicin—testicular cancer	0.000595	0.000615	CcSEcCtD
Imiquimod—Flushing—Epirubicin—testicular cancer	0.000593	0.000614	CcSEcCtD
Imiquimod—Rhinitis—Doxorubicin—testicular cancer	0.000593	0.000613	CcSEcCtD
Imiquimod—Haemorrhage—Doxorubicin—testicular cancer	0.000592	0.000612	CcSEcCtD
Imiquimod—Pharyngitis—Doxorubicin—testicular cancer	0.000587	0.000607	CcSEcCtD
Imiquimod—Urinary tract disorder—Doxorubicin—testicular cancer	0.000584	0.000604	CcSEcCtD
Imiquimod—Asthenia—Etoposide—testicular cancer	0.000582	0.000601	CcSEcCtD
Imiquimod—Connective tissue disorder—Doxorubicin—testicular cancer	0.000581	0.000601	CcSEcCtD
Imiquimod—Angiopathy—Epirubicin—testicular cancer	0.00058	0.0006	CcSEcCtD
Imiquimod—Urethral disorder—Doxorubicin—testicular cancer	0.00058	0.0006	CcSEcCtD
Imiquimod—Immune system disorder—Epirubicin—testicular cancer	0.000578	0.000597	CcSEcCtD
Imiquimod—Mediastinal disorder—Epirubicin—testicular cancer	0.000576	0.000596	CcSEcCtD
Imiquimod—Back pain—Methotrexate—testicular cancer	0.000575	0.000595	CcSEcCtD
Imiquimod—Chills—Epirubicin—testicular cancer	0.000574	0.000593	CcSEcCtD
Imiquimod—Pruritus—Etoposide—testicular cancer	0.000573	0.000593	CcSEcCtD
Imiquimod—Arrhythmia—Epirubicin—testicular cancer	0.000571	0.000591	CcSEcCtD
Imiquimod—Visual impairment—Doxorubicin—testicular cancer	0.00057	0.00059	CcSEcCtD
Imiquimod—Alopecia—Epirubicin—testicular cancer	0.000565	0.000584	CcSEcCtD
Imiquimod—Vomiting—Cisplatin—testicular cancer	0.000562	0.000582	CcSEcCtD
Imiquimod—Mental disorder—Epirubicin—testicular cancer	0.00056	0.000579	CcSEcCtD
Imiquimod—Erythema multiforme—Doxorubicin—testicular cancer	0.000559	0.000578	CcSEcCtD
Imiquimod—Rash—Cisplatin—testicular cancer	0.000558	0.000577	CcSEcCtD
Imiquimod—Dermatitis—Cisplatin—testicular cancer	0.000557	0.000576	CcSEcCtD
Imiquimod—Malnutrition—Epirubicin—testicular cancer	0.000557	0.000576	CcSEcCtD
Imiquimod—Erythema—Epirubicin—testicular cancer	0.000557	0.000576	CcSEcCtD
Imiquimod—Diarrhoea—Etoposide—testicular cancer	0.000555	0.000573	CcSEcCtD
Imiquimod—Eye disorder—Doxorubicin—testicular cancer	0.000553	0.000572	CcSEcCtD
Imiquimod—Ill-defined disorder—Methotrexate—testicular cancer	0.000552	0.000571	CcSEcCtD
Imiquimod—Tinnitus—Doxorubicin—testicular cancer	0.000552	0.00057	CcSEcCtD
Imiquimod—Flushing—Doxorubicin—testicular cancer	0.000549	0.000568	CcSEcCtD
Imiquimod—Back pain—Epirubicin—testicular cancer	0.000538	0.000557	CcSEcCtD
Imiquimod—Angiopathy—Doxorubicin—testicular cancer	0.000537	0.000555	CcSEcCtD
Imiquimod—Malaise—Methotrexate—testicular cancer	0.000536	0.000555	CcSEcCtD
Imiquimod—Dizziness—Etoposide—testicular cancer	0.000536	0.000554	CcSEcCtD
Imiquimod—Immune system disorder—Doxorubicin—testicular cancer	0.000534	0.000553	CcSEcCtD
Imiquimod—Mediastinal disorder—Doxorubicin—testicular cancer	0.000533	0.000551	CcSEcCtD
Imiquimod—Chills—Doxorubicin—testicular cancer	0.000531	0.000549	CcSEcCtD
Imiquimod—Arrhythmia—Doxorubicin—testicular cancer	0.000529	0.000547	CcSEcCtD
Imiquimod—Nausea—Cisplatin—testicular cancer	0.000525	0.000543	CcSEcCtD
Imiquimod—Alopecia—Doxorubicin—testicular cancer	0.000523	0.000541	CcSEcCtD
Imiquimod—Cough—Methotrexate—testicular cancer	0.000519	0.000537	CcSEcCtD
Imiquimod—Mental disorder—Doxorubicin—testicular cancer	0.000518	0.000536	CcSEcCtD
Imiquimod—Ill-defined disorder—Epirubicin—testicular cancer	0.000517	0.000534	CcSEcCtD
Imiquimod—Convulsion—Methotrexate—testicular cancer	0.000515	0.000533	CcSEcCtD
Imiquimod—Vomiting—Etoposide—testicular cancer	0.000515	0.000533	CcSEcCtD
Imiquimod—Erythema—Doxorubicin—testicular cancer	0.000515	0.000533	CcSEcCtD
Imiquimod—Malnutrition—Doxorubicin—testicular cancer	0.000515	0.000533	CcSEcCtD
Imiquimod—Agitation—Epirubicin—testicular cancer	0.000512	0.000529	CcSEcCtD
Imiquimod—Rash—Etoposide—testicular cancer	0.000511	0.000528	CcSEcCtD
Imiquimod—Dermatitis—Etoposide—testicular cancer	0.000511	0.000528	CcSEcCtD
Imiquimod—Headache—Etoposide—testicular cancer	0.000508	0.000525	CcSEcCtD
Imiquimod—Chest pain—Methotrexate—testicular cancer	0.000506	0.000524	CcSEcCtD
Imiquimod—Arthralgia—Methotrexate—testicular cancer	0.000506	0.000524	CcSEcCtD
Imiquimod—Myalgia—Methotrexate—testicular cancer	0.000506	0.000524	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000503	0.00052	CcSEcCtD
Imiquimod—Malaise—Epirubicin—testicular cancer	0.000502	0.000519	CcSEcCtD
Imiquimod—Discomfort—Methotrexate—testicular cancer	0.0005	0.000517	CcSEcCtD
Imiquimod—Syncope—Epirubicin—testicular cancer	0.000499	0.000516	CcSEcCtD
Imiquimod—Back pain—Doxorubicin—testicular cancer	0.000498	0.000515	CcSEcCtD
Imiquimod—Palpitations—Epirubicin—testicular cancer	0.000492	0.000509	CcSEcCtD
Imiquimod—Loss of consciousness—Epirubicin—testicular cancer	0.000489	0.000506	CcSEcCtD
Imiquimod—Cough—Epirubicin—testicular cancer	0.000486	0.000502	CcSEcCtD
Imiquimod—Convulsion—Epirubicin—testicular cancer	0.000482	0.000499	CcSEcCtD
Imiquimod—Infection—Methotrexate—testicular cancer	0.000482	0.000499	CcSEcCtD
Imiquimod—Nausea—Etoposide—testicular cancer	0.000481	0.000498	CcSEcCtD
Imiquimod—Hypertension—Epirubicin—testicular cancer	0.000481	0.000497	CcSEcCtD
Imiquimod—Ill-defined disorder—Doxorubicin—testicular cancer	0.000478	0.000494	CcSEcCtD
Imiquimod—Nervous system disorder—Methotrexate—testicular cancer	0.000476	0.000492	CcSEcCtD
Imiquimod—Myalgia—Epirubicin—testicular cancer	0.000474	0.00049	CcSEcCtD
Imiquimod—Arthralgia—Epirubicin—testicular cancer	0.000474	0.00049	CcSEcCtD
Imiquimod—Chest pain—Epirubicin—testicular cancer	0.000474	0.00049	CcSEcCtD
Imiquimod—Agitation—Doxorubicin—testicular cancer	0.000473	0.000489	CcSEcCtD
Imiquimod—Anxiety—Epirubicin—testicular cancer	0.000472	0.000488	CcSEcCtD
Imiquimod—Skin disorder—Methotrexate—testicular cancer	0.000472	0.000488	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000471	0.000487	CcSEcCtD
Imiquimod—Hyperhidrosis—Methotrexate—testicular cancer	0.000469	0.000485	CcSEcCtD
Imiquimod—Discomfort—Epirubicin—testicular cancer	0.000468	0.000484	CcSEcCtD
Imiquimod—Malaise—Doxorubicin—testicular cancer	0.000464	0.00048	CcSEcCtD
Imiquimod—Dry mouth—Epirubicin—testicular cancer	0.000463	0.000479	CcSEcCtD
Imiquimod—Anorexia—Methotrexate—testicular cancer	0.000463	0.000478	CcSEcCtD
Imiquimod—Syncope—Doxorubicin—testicular cancer	0.000462	0.000478	CcSEcCtD
Imiquimod—Palpitations—Doxorubicin—testicular cancer	0.000455	0.000471	CcSEcCtD
Imiquimod—Oedema—Epirubicin—testicular cancer	0.000454	0.00047	CcSEcCtD
Imiquimod—Loss of consciousness—Doxorubicin—testicular cancer	0.000453	0.000468	CcSEcCtD
Imiquimod—Infection—Epirubicin—testicular cancer	0.000451	0.000467	CcSEcCtD
Imiquimod—Cough—Doxorubicin—testicular cancer	0.000449	0.000465	CcSEcCtD
Imiquimod—Shock—Epirubicin—testicular cancer	0.000447	0.000462	CcSEcCtD
Imiquimod—Convulsion—Doxorubicin—testicular cancer	0.000446	0.000461	CcSEcCtD
Imiquimod—Nervous system disorder—Epirubicin—testicular cancer	0.000446	0.000461	CcSEcCtD
Imiquimod—Hypertension—Doxorubicin—testicular cancer	0.000445	0.00046	CcSEcCtD
Imiquimod—Tachycardia—Epirubicin—testicular cancer	0.000443	0.000458	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000442	0.000457	CcSEcCtD
Imiquimod—Skin disorder—Epirubicin—testicular cancer	0.000441	0.000456	CcSEcCtD
Imiquimod—Hyperhidrosis—Epirubicin—testicular cancer	0.000439	0.000454	CcSEcCtD
Imiquimod—Insomnia—Methotrexate—testicular cancer	0.000439	0.000454	CcSEcCtD
Imiquimod—Myalgia—Doxorubicin—testicular cancer	0.000439	0.000453	CcSEcCtD
Imiquimod—Arthralgia—Doxorubicin—testicular cancer	0.000439	0.000453	CcSEcCtD
Imiquimod—Chest pain—Doxorubicin—testicular cancer	0.000439	0.000453	CcSEcCtD
Imiquimod—Anxiety—Doxorubicin—testicular cancer	0.000437	0.000452	CcSEcCtD
Imiquimod—Paraesthesia—Methotrexate—testicular cancer	0.000436	0.000451	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000435	0.00045	CcSEcCtD
Imiquimod—Discomfort—Doxorubicin—testicular cancer	0.000433	0.000448	CcSEcCtD
Imiquimod—Anorexia—Epirubicin—testicular cancer	0.000433	0.000448	CcSEcCtD
Imiquimod—Dyspnoea—Methotrexate—testicular cancer	0.000433	0.000448	CcSEcCtD
Imiquimod—Somnolence—Methotrexate—testicular cancer	0.000432	0.000446	CcSEcCtD
Imiquimod—Dry mouth—Doxorubicin—testicular cancer	0.000429	0.000443	CcSEcCtD
Imiquimod—Dyspepsia—Methotrexate—testicular cancer	0.000427	0.000442	CcSEcCtD
Imiquimod—Decreased appetite—Methotrexate—testicular cancer	0.000422	0.000436	CcSEcCtD
Imiquimod—Oedema—Doxorubicin—testicular cancer	0.00042	0.000435	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000419	0.000433	CcSEcCtD
Imiquimod—Fatigue—Methotrexate—testicular cancer	0.000419	0.000433	CcSEcCtD
Imiquimod—Infection—Doxorubicin—testicular cancer	0.000418	0.000432	CcSEcCtD
Imiquimod—Pain—Methotrexate—testicular cancer	0.000415	0.000429	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000414	0.000428	CcSEcCtD
Imiquimod—Shock—Doxorubicin—testicular cancer	0.000414	0.000428	CcSEcCtD
Imiquimod—Nervous system disorder—Doxorubicin—testicular cancer	0.000412	0.000426	CcSEcCtD
Imiquimod—Insomnia—Epirubicin—testicular cancer	0.000411	0.000425	CcSEcCtD
Imiquimod—Tachycardia—Doxorubicin—testicular cancer	0.00041	0.000424	CcSEcCtD
Imiquimod—Skin disorder—Doxorubicin—testicular cancer	0.000408	0.000422	CcSEcCtD
Imiquimod—Paraesthesia—Epirubicin—testicular cancer	0.000408	0.000422	CcSEcCtD
Imiquimod—Hyperhidrosis—Doxorubicin—testicular cancer	0.000406	0.00042	CcSEcCtD
Imiquimod—Dyspnoea—Epirubicin—testicular cancer	0.000405	0.000419	CcSEcCtD
Imiquimod—Somnolence—Epirubicin—testicular cancer	0.000404	0.000418	CcSEcCtD
Imiquimod—Anorexia—Doxorubicin—testicular cancer	0.000401	0.000414	CcSEcCtD
Imiquimod—Feeling abnormal—Methotrexate—testicular cancer	0.0004	0.000414	CcSEcCtD
Imiquimod—Dyspepsia—Epirubicin—testicular cancer	0.0004	0.000413	CcSEcCtD
Imiquimod—Gastrointestinal pain—Methotrexate—testicular cancer	0.000397	0.00041	CcSEcCtD
Imiquimod—Decreased appetite—Epirubicin—testicular cancer	0.000395	0.000408	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000392	0.000406	CcSEcCtD
Imiquimod—Fatigue—Epirubicin—testicular cancer	0.000392	0.000405	CcSEcCtD
Imiquimod—Pain—Epirubicin—testicular cancer	0.000389	0.000402	CcSEcCtD
Imiquimod—Urticaria—Methotrexate—testicular cancer	0.000386	0.000399	CcSEcCtD
Imiquimod—Body temperature increased—Methotrexate—testicular cancer	0.000384	0.000397	CcSEcCtD
Imiquimod—Abdominal pain—Methotrexate—testicular cancer	0.000384	0.000397	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000383	0.000396	CcSEcCtD
Imiquimod—Insomnia—Doxorubicin—testicular cancer	0.00038	0.000393	CcSEcCtD
Imiquimod—Paraesthesia—Doxorubicin—testicular cancer	0.000377	0.00039	CcSEcCtD
Imiquimod—Dyspnoea—Doxorubicin—testicular cancer	0.000375	0.000388	CcSEcCtD
Imiquimod—Feeling abnormal—Epirubicin—testicular cancer	0.000374	0.000387	CcSEcCtD
Imiquimod—Somnolence—Doxorubicin—testicular cancer	0.000374	0.000386	CcSEcCtD
Imiquimod—Gastrointestinal pain—Epirubicin—testicular cancer	0.000372	0.000384	CcSEcCtD
Imiquimod—Dyspepsia—Doxorubicin—testicular cancer	0.00037	0.000383	CcSEcCtD
Imiquimod—Decreased appetite—Doxorubicin—testicular cancer	0.000365	0.000378	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000363	0.000375	CcSEcCtD
Imiquimod—Fatigue—Doxorubicin—testicular cancer	0.000362	0.000375	CcSEcCtD
Imiquimod—Urticaria—Epirubicin—testicular cancer	0.000361	0.000373	CcSEcCtD
Imiquimod—Pain—Doxorubicin—testicular cancer	0.000359	0.000372	CcSEcCtD
Imiquimod—Abdominal pain—Epirubicin—testicular cancer	0.000359	0.000371	CcSEcCtD
Imiquimod—Body temperature increased—Epirubicin—testicular cancer	0.000359	0.000371	CcSEcCtD
Imiquimod—Hypersensitivity—Methotrexate—testicular cancer	0.000358	0.00037	CcSEcCtD
Imiquimod—Asthenia—Methotrexate—testicular cancer	0.000348	0.00036	CcSEcCtD
Imiquimod—Feeling abnormal—Doxorubicin—testicular cancer	0.000346	0.000358	CcSEcCtD
Imiquimod—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000344	0.000355	CcSEcCtD
Imiquimod—Pruritus—Methotrexate—testicular cancer	0.000343	0.000355	CcSEcCtD
Imiquimod—Hypersensitivity—Epirubicin—testicular cancer	0.000335	0.000346	CcSEcCtD
Imiquimod—Urticaria—Doxorubicin—testicular cancer	0.000334	0.000345	CcSEcCtD
Imiquimod—Abdominal pain—Doxorubicin—testicular cancer	0.000332	0.000344	CcSEcCtD
Imiquimod—Body temperature increased—Doxorubicin—testicular cancer	0.000332	0.000344	CcSEcCtD
Imiquimod—Diarrhoea—Methotrexate—testicular cancer	0.000332	0.000343	CcSEcCtD
Imiquimod—Asthenia—Epirubicin—testicular cancer	0.000326	0.000337	CcSEcCtD
Imiquimod—Pruritus—Epirubicin—testicular cancer	0.000321	0.000332	CcSEcCtD
Imiquimod—Dizziness—Methotrexate—testicular cancer	0.000321	0.000332	CcSEcCtD
Imiquimod—Diarrhoea—Epirubicin—testicular cancer	0.000311	0.000321	CcSEcCtD
Imiquimod—Hypersensitivity—Doxorubicin—testicular cancer	0.00031	0.00032	CcSEcCtD
Imiquimod—Vomiting—Methotrexate—testicular cancer	0.000309	0.000319	CcSEcCtD
Imiquimod—Rash—Methotrexate—testicular cancer	0.000306	0.000316	CcSEcCtD
Imiquimod—Dermatitis—Methotrexate—testicular cancer	0.000306	0.000316	CcSEcCtD
Imiquimod—Headache—Methotrexate—testicular cancer	0.000304	0.000314	CcSEcCtD
Imiquimod—Asthenia—Doxorubicin—testicular cancer	0.000302	0.000312	CcSEcCtD
Imiquimod—Dizziness—Epirubicin—testicular cancer	0.0003	0.000311	CcSEcCtD
Imiquimod—Pruritus—Doxorubicin—testicular cancer	0.000297	0.000308	CcSEcCtD
Imiquimod—Vomiting—Epirubicin—testicular cancer	0.000289	0.000299	CcSEcCtD
Imiquimod—Nausea—Methotrexate—testicular cancer	0.000288	0.000298	CcSEcCtD
Imiquimod—Diarrhoea—Doxorubicin—testicular cancer	0.000288	0.000297	CcSEcCtD
Imiquimod—Rash—Epirubicin—testicular cancer	0.000286	0.000296	CcSEcCtD
Imiquimod—Dermatitis—Epirubicin—testicular cancer	0.000286	0.000296	CcSEcCtD
Imiquimod—Headache—Epirubicin—testicular cancer	0.000285	0.000294	CcSEcCtD
Imiquimod—Dizziness—Doxorubicin—testicular cancer	0.000278	0.000287	CcSEcCtD
Imiquimod—Nausea—Epirubicin—testicular cancer	0.00027	0.000279	CcSEcCtD
Imiquimod—Vomiting—Doxorubicin—testicular cancer	0.000267	0.000276	CcSEcCtD
Imiquimod—Rash—Doxorubicin—testicular cancer	0.000265	0.000274	CcSEcCtD
Imiquimod—Dermatitis—Doxorubicin—testicular cancer	0.000265	0.000274	CcSEcCtD
Imiquimod—Headache—Doxorubicin—testicular cancer	0.000263	0.000272	CcSEcCtD
Imiquimod—Nausea—Doxorubicin—testicular cancer	0.00025	0.000258	CcSEcCtD
